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Human Wharton’s jelly-derived mesenchymal stem cells express several 
immunomodulatory molecules both in their naïve state and hepatocyte-like 
differentiated progeny: prospects for their use in liver diseases. 
Anzalone R.1, Lo Iacono M.1, Corrao S.1, Magno F.1, Loria T. 1, Di Stefano A.2, 
Giannuzzi P.2, Zummo G.1, Farina F.1, La Rocca G.1 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Wharton’s jelly (WJ), the main constituent of umbilical cord, is a reliable source of 
mesenchymal stem cells (MSC). WJ-MSC show unique ability in crossing lineage 
borders. As other extraembryonic mesenchymal populations (placenta and amnion-
derived cells), WJ-MSC express several immunomodulatory molecules, essential during 
the initial phases of human development. Indeed, our recent work pointed out the 
expression of non-classical HLA molecules as HLA-G in such cells, together with a 
favorable combination of B7 costimulators. Very few data in literature suggest that some 
of the immune features of the naïve cells are maintained after performing differentiation.  
The aim of this work was extending the knowledge on the expression of 
immunomodulatory molecules by naïve and differentiated WJ-MSC. To this purpose, WJ-
MSC underwent differentiation to osteoblasts, adipocytes and hepatocyte-like cells. 
Differentiated cells were characterized, by both RT-PCR, ICC and histological stains for 
the acquisistion of the desired phenotypical features. RT-PCR and ICC were used to 
investigate the differential expression of immune-related molecules in control and 
differentiated cells.  
WJ-MSC resulted expressing diverse immunomodulatory molecules which spans from 
non-classical type I HLAs (i.e. HLA-E, -F, -G) , to further members of the B7 family, and 
of the CEA superfamily, for all of which in vivo immunomodulating functions are known. 
In addition, we demonstrated for the first time that the expression of these molecules is 
maintained after performing osteogenic, adipogenic or hepatogenic differentiation. 
Further experiments are undergoing to better evaluating the implications of these findings 
in the evolving field of liver regenerative medicine. 
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